FDA
-
-
-
-
-
-
-
Femasys secures new patents for FemBloc polymer in U.S. and abroad
-
-
-
-
-
-
-
Femasys Expands Fertility Care Portfolio in Europe with CE Mark Approval for FemHSG™ Catheter
-
-
-
-
-
-
-
Femasys names John Canning as chief operating officer
-
-
-
-
-
-
-
Lake Street Starts Femasys Inc. (FEMY) at Buy
-
-
-
-
-
-
-
Femasys receives 180-day Nasdaq extension to meet $1 minimum bid price
-
-
-
-
-
-
-
PharmaCyte Biotech Successfully Monetizes Femasys Stake, Strengthening Cash Position and Underscoring Strategic Capital Deployment
-
-
-
-
-
-
-
Femasys to Exhibit at the ASRM 2025 Scientific Congress & Expo
-
330,721 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

